Celldex Therapeutics | CLDX - Actif À Court Terme





Actif À Court Terme Changement Date
AbbVie USD 29.06B 523M 2025-12
Agenus USD 133.44M 514K 2025-12
Amgen USD 29.06B 1.17B 2025-12
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Celldex Therapeutics USD 534.66M 69.68M 2025-12
Glaxosmithkline GBP 23.59B 390.44M 2025-12
Nektar Therapeutics USD 281.36M 94.79M 2025-09
Northwest Biotherapeutics USD 7.2M 1.04M 2025-09
Pfizer USD 46.92B 3.22B 2025-09
Rigel Pharmaceuticals USD 214.93M 39.53M 2025-09
Roche Holding CHF 38.73B 3.03B 2025-12